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Abstract
An attribution method was developed to interpret a recurrent neural network (RNN)
trained to predict a child’s risk of ICU mortality using multi-modal, time series data
in the Electronic Medical Records. By learning a sparse, binary mask that highlights
salient features of the input data, critical features determining an individual patient’s
severity of illness could be identified. The method, called Learned Binary Masks
(LBM), demonstrated that the RNN used different feature sets specific to each
patient’s illness; and further, the features highlighted aligned with clinical intuition
of the patient’s disease trajectories. LBM was also used to identify the most salient
features across model, analogous to “feature importance” computed in the Random
Forest. This measure of the RNN’s feature importance was further used to select
the 25% most used features for training a second RNN model. Interestingly, but
not surprisingly, the second model maintained similar performance to the model
trained on all features. LBM is data-agnostic and can be used to interpret the
predictions of any differentiable model.
1 Introduction
Despite the widespread success of deep learning algorithms, acceptance has been impeded by their
lack of transparency, especially in healthcare where decisions can result in life and death [1]. In
response, research efforts to interpret these models have increased recently [2, 3, 4, 5, 6]. Olah et al.
[7] establishes two major research areas in neural network interpretability: attribution and feature
visualization. Attribution focuses on why the network made the predictions by identifying inputs
that were salient for making the predictions [6]. Feature visualization addresses questions about the
network by finding what concepts the model learned [8].
The majority of existing attribution approaches interpret neural networks by using derivatives. At-
tributions are visualized with respect to the inputs; for example, pixels are highlighted based on
their rankings computed from the chosen attribution method. The application of these methods
and visualizations of their results have mostly been limited to the domains of images and texts —
single-sensor inputs [9]. In contrast, the Electronic Medical Records (EMR), a treasure trove of data
capturing patient events, contain an eclectic collection of data ranging from continuous physiology
(heart rate), categoricals (Glascow Coma Score), binary (culture labs), and unstructured texts (clinical
notes) [10]. Consequently, it is nontrivial how current attribution methods translate to multi-modal,
time-series data contained in EMR; and further, how to analyze and visualize their results.
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This work developed an attribution method for interpreting a recurrent neural network (RNN) model
using multi-modal EMR data. In addition, the attributions are presented in a way such that visualizing
and analyzing the breadth of information are intuitive and meaningful for clinicians. This ensures
that practical users (clinicians) can gain confidence in the highly accurate, "black-box" model as well
as receive relevant, actionable information at scale. The attribution method, called Learned Binary
Masks, was used to interpret a RNN model trained to predict an individual child’s risk of mortality
using the patient’s EMR.
2 Related Work
Saliency methods provide insights into the network’s prediction by using the differentiability of
neural networks [11]. A majority of applications of these methods have been limited to single-
sensor inputs such as pixels in images and characters in text [9]. For example, they can highlight
which pixels contributed to the model’s belief that a specific class of interest was in the image
[2, 3, 4, 5, 6]. Similarly, they can highlight which words in a sentence were most impactful to the
model in determining the sentiment of a sentence or prediction of the next word [12, 13]. In both
problems, they are typically visualized as heatmaps over the inputs, ranking pixels or characters in a
word based on their impact on the prediction.
In contrast to these unimodal problems, EMR can span hundreds of features and data-modalities.
For example, a heart rate may be measured every hour and stored as an integer ranging from 50
to 250 beats per minute, while pupil response may be measured every 4 hours and represented
qualitatively as {Non-reactive, Pinpoint, or Brisk}. Comparisons and visualizations of attributions
from multi-modal data are more complex — e.g. how does a gradient with respect to heart rate
(∂y/∂x, x ∈ [50, 250]) compare with the gradient with respect to pupil response (∂y/∂x, x ∈
{Non-reactive, Pinpoint, Brisk})?
The attribution method developed here extends the occlusion method in Fong and Vedaldi [5].
However, instead of learning a mask that optimally deletes information to reduce the class prediction
to zero, a binary mask is learned that optimally keeps information required to generate the same
prediction. The binary property of the mask ensures that attribution comparisons between multi-modal
data simply indicate the salient variables used at each prediction.
3 Application: Dynamic Prediction of Risk of ICU Mortality using RNNs
Numerous severity of illness (SOI) and mortality scoring systems have emerged over the last three
decades [14, 15, 16, 17]. Over many years, these systems have been refined with increasingly larger
number of patients [18, 19, 20, 21, 22, 23]. Despite the number of SOI scores developed, their
primary use have been limited to evaluating ICU (Intensive Care Unit) performance and selecting
patient cohorts for clinical trials [24, 25, 26], instead of guiding treatments and interventions [27].
One reason for this is because the scores are not dynamic – they use features computed over fixed
time windows of data (e.g. 12 hours of data from ICU admission) and generate a static risk of
mortality (ROM) score at a single point in time (e.g. at the 12th hour). Another reason is because the
predictions are merely descriptive – there is no accompanying attribution or reasoning for the models’
individual patient predictions.
An RNN model was trained to predict ICU mortality and was the use case for the attribution method
described in Section 4. The RNN generates a dynamic ROM score and can elegantly update its
prediction as data is acrrued. By using the attribution method, salient features unique to the patient
can be highlighted, illuminating why the model made its prediction specific to that patient, and thus
providing the clinician with actionable information. By understanding both how sick the patient is
(model’s prediction) and why they’re sick (LBM attributions), clinicians can use this information to
guide treatments and allocations of reasources in real-time at the bedside.
De-identified patient EMR data collected in the Pediatric Intensive Care Unit (PICU) of a tertiary
hospital was used. The data consisted of 9955 patient-encounters (7358 patients) admitted from
2009 to 2017 (4% mortality rate). Each patient-encounter contained irregularly sampled physiologic
observations, laboratory results, drugs, and interventions (e.g. intubation parameters) over their ICU
stay. Also collected were the patient’s demographics, diagnoses, and outcomes (e.g. ICU mortality).
The data was preprocessed as described in [28], resulting in a T × N matrix per patient (called
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“patient-matrix"). N = 270 is the number of features (constant across all patients), while T is the
number of distinct time points when a patient had a measurement (varies across patients). The
features were chosen based on their frequency of measurement and relevance to the outcome. The
chosen features are listed in Appendix B.
The patient-matrix is the input to a many-to-many RNN trained to predict an individual patient’s
ROM. Each time step (column of patient-matrix) generates a ROM prediction. Training details such
as the network architecture, hyper-parameters, and implementation are described in Appendix A. The
model was evaluated using Area under the Receiver Operating Characteristic (AUROC) curve after
12 hours of measurements. This allowed for comparisons with SOI scores deployed in the pediatric
ICU: PIM2 and PRISM3-12 [22, 20]. Three RNN models were trained with different initialized
weights and sequencing of mini-batches. Their averaged 12th hour AUC (0.940±0.004) significantly
outperformed that of PIM2 (0.880) and PRISM3-12 (0.896).
4 Learned Binary Masks
A many-to-many RNN maps an input sequence, x1:T (the patient-matrix), to an output sequence,
y1:T (risk of mortality), of the same length:
f(Θ;x1:T ) = y1:T , (1)
where Θ denotes the parameters of the trained network f . LBM attributes the predictions to the input
by finding a sparse binary mask, such that the trained network, when given the masked input, outputs
the same prediction as the original input data. Mathematically, this is expressed by
f
(
Θ;x1:T  σ (A×m1:T )
) ≈ f(Θ;x1:T ), (2)
whereM1:T ≡ σ (A×m1:T ) is the learned sparse mask, is the element-wise matrix multiplication
operator, σ(x) ≡ 11+e−x , and A is a constant. This is implemented as a new layer to the original
network f , whose weights are m1:T ∈ RT×N and output operation is σ (A×m1:T ). Let y˜1:T ≡
f(Θ;x1:T M1:T ). Then the learned sparse mask M1:T is found by using backpropagation to
minimize the loss function:
L(M1:T ) = Σ
T
t=1
∣∣y(t)− y˜(t)∣∣+ λ1‖M1:T ‖1 , (3)
where λ1 is a constant, and‖M1:T ‖1 =
∑T
t=1
∑N
j=1 |M jt |. If the first term,
∑T
t=1 |yt − y˜t|, is zero,
then the two output sequences (y1:T – generated by the original input sequence (x1:T ), and y˜1:T –
generated by the masked input sequence (x1:T M1:T )), match each other. Minimizing the second
term, λ1‖M1:T ‖1, encourages the maskM1:T to be sparse, equivalent to asking that only the salient
inputs be kept.
SinceM1:T is the output of σ,M1:T ∈ [0, 1]T×N . If M jt = 0, then the jth feature at time t can be
set to zero without changing the output, i.e. M jt was not critical to making the prediction, and the
population mean was sufficient information. If M jt = 1, then x
j
t was a critical measurement in the
model’s prediction. On the other hand, if M jt ∈ (0, 1), then xjt ·M jt is a scaled value of xjt and no
longer represents the presence or removal of the feature with respect to its contribution to the model’s
prediction, which makes interpretation challenging.
4.1 Learned Binary Masks via 2-step Optimization
Comparing non-binary values of M jt poses interpretability challenges. Therefore, the algorithm
is modified to enforce an additional constraint: the mask can take on only binary values, namely
M jt ∈ {0, 1}. This constraint cannot be integrated into optimization methods that use derivatives
such as backpropagation. Therefore, the algorithm is modified by using a 2-step optimization process.
The first step uses backpropagation-optimization to find an initial mask whose values are close to 0 or
1. The second step fine-tunes the mask for interpretability by binarizing the mask using brute-force
optimization. The initial mask is computed as described previously but augmented with an additional
regularizer that optimizes a mask with elements closer to 0 or 1.
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Step 1: Find an initial maskM1:T ∈ [0, 1]T×N using backpropagation.
Let y˜ ≡ f (Θ;x1:T  σ (A×m1:T )), where σ(x) = 11+e−x , and A is a constant. The first mask
M1:T ≡ σ (A×m1:T ) is computed by minimizing the loss function:
L(M1:T ) = Σ
T
t=1
∣∣y(t)− y˜(t)∣∣+ λ11‖M1:T ‖1 + λ2H (M1:T > 0.5,M1:T ) (4)
where H is the binary cross-entropy function, and λ2 is a constant. This loss function parallels
equation 3, but adds a binary cross-entropy term to push the values of the mask closer to 0 or 1.
Equation 4, like Equation 3, can be minimized by using backpropagation mechanics.
Step 2: Binarize the initial maskM1:T ∈ [0, 1]T×N using brute-force optimization.
The maskM1:T is binarized by finding a threshold mask τ 1:T such that
f
(
Θ;x1:T  (M1:T > τ 1:T )
) ≈ f (Θ;x1:T ) . (5)
Redefining y˜ ≡ f (Θ;x1:T  (M1:T > τ 1:T )), then τ 1:T is found by minimizing the loss function:
L(τ 1:T ) = Σ
T
t=1
∣∣y(t)− y˜(t)∣∣+ λ21‖M1:T > τ˜1:T ‖1 . (6)
Equation 6 can be minimized using brute-force grid-search of threshold values τ jt ∈ [0, 1]. The final
result is a binary mask,B1:T ≡ (M1:T > τ 1:T ). The binary nature of each Bjt indicates whether xjt
was critical in making the prediction yˆ1:T and allows for comparisons between multi-modal input
features.
4.2 Implementation Details
Step 1’s Equation 4 was minimized using RMSProp [29] with A = −5, λ11 = 0.005, and λ2 = 0.5.
The learning rate was initialized to 0.1 and reduced by 10 if it did not decrease after 5 iterations. Step
1’s optimization is stopped if learning rate was reduced by 10 for a total of 3 decimations, or after
5000 iterations.
Step 2’s Equation 6 was minimized using brute-force grid search of τ 1:T ∈ [0, 1]T×N and λ21 = 10−4.
The brute-force method can be practically reduced by optimizing in two steps. First, the threshold
mask τ 1:T is initialized with a single threshold value τi found by minimizing Equation 6. The
optimization is further reduced by only optimizing time-steps τ (t) when
∣∣y(t)− y˜(t)∣∣ > , where
 = 0.01 is a minimal allowed difference between the model’s prediction when using the masked
input sequence (x1:T M1:T ) versus the original input sequence (x1:T ).
Learned Binary Masks was developed to interpret the RNN trained to predict ROM using EMR data.
Although the notation used were specific to time-series data and RNNs, the technique is data-agnostic
and can be applied to any differentiable model. LBM was implemented using keras, a high-level
Python neural networks API [30]. The code will be made publicly available on GitHub.
LBM is a computationally expensive 2-step optimization process applied to each patient. Moreover,
because patients have variable sequence lengths, finding an optimal binary mask for each patient can
vary widely. For reference, using a Titan V Volta GPU and keras with Theano-backend, it takes 0.01
seconds to generate predictions for a patient with 500 time steps and 270 features. On the other hand,
it takes 30 minutes to compute LBM on the same data, which can be heavily improved but is still
reasonable in application.
4.3 Interpreting Attributions
Understanding why a model predicted an increase in ROM from 0.1 to 0.9 is more useful than
understanding why a model made a single ROM prediction of 0.9. LBM attributions can highlight
what features contributed the most to the model’s shift in prediction by computing the average LBM
attribution over the time window of interest:
Bti:tf ≡ Σtft=tiB(t)/n(ti, tf ), (7)
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where n(ti, tf ) is the number of time steps in the time interval [ti, tf ]. Bti:tf ∈ RN is a vector
describing the average use of each feature in making the prediction from t = ti to t = tf .
Feature Importance An individual patient p has an associated attribution matrixBp1:Tp ∈ RTp×N ,
where Tp is the total time steps for that patient’s entire ICU stay. Setting ti = 1 and tf = Tp in
Equation 7 yields a vector containing the frequency that each feature was used by the model to
generate this patient’s ROM scores over their entire ICU stay. This vector, denoted byB
p
1:Tp , can be
averaged over all P patients to yield a population-level feature contribution vector:
F ≡ ΣPp=1B
p
1:Tp . (8)
The vector F ∈ RN is analogous to “feature importance” computed in machine learning models
such as the Random Forest [31]. Feature importance should be averaged over the population in the
validation set, Pvalid, because the training set is used for optimizing the weights and test set for
performance analysis. In contrast to ranking features based on their direct effects on the model’s
predictive performance, the LBM’s “feature importance” as computed above is a measure of how
frequently the feature is required for making predictions, independent of whether it improves the
model’s performance.
Figure 1: Example of the modular visualization interface for interpreting attributions alongside data.
4.4 Visualizing Attributions for Interpretation
On average, patients stay 4.5 days in the ICU with 230 unique time measurements. With over 270
features, visualizing the totality of an individual patient’s data can be overwhelming, let alone also
visualizing the attribution matrices. Moreover, any visualization should be intuitive for clinicians and
harmonize into their workflow.
To achieve this, individual LBM attribution matrices along with the patient matrices (described in
Section 3) are visualized using a modular interface that mirrors the way clinicians view the data. The
interface contains a chart displaying the patient’s ROM. Also plotted on the same chart is an image
representation of the patient’s LBM attribution matrixB1:T , with time on the x-axis, features on the
y-axis. White pixels indicate where Mft = 0, while red pixels indicate M
f
t = 1. Additional charts
(scatter plots) of the patient’s data are visualized in alignment with the ROM chart and can be added
to or removed from the interface. Furthermore, the clinician can select time windows of interest and
compute the average attribution over these time windows. These average attributions are displayed as
bar-plots and describe the average importance of each feature in making the prediction over the time
windows of interest. An example of visualization is shown in Figure 1.
5
5 Results
5.1 Patient-Level Attributions
LBM was computed to interpret individual patient ROM predictions generated by the RNN. Presented
are examples of two patients in the test dataset with similar ROM predictions but different primary
diagnoses. The first is a 1 year old male weighing 10 kg with a primary diagnosis of sepsis (infection);
the second is a 14 year old female weighing 74 kg with a primary diagnosis of acute respiratory
distress syndrome (ARDS). Both patients do not survive their ICU stay. The ROM predictions for the
two patients are shown in Figure 2. In both patients, ROM predictions start low but quickly increase
over a short time window, eventually approaching 1. To understand why the model increased its
prediction in the highlighted windows, LBM attributions were averaged across each patient using
Equation 7: BPatient 115:20 andBPatient 25:7; this is visualized in Figure 3.
(a) Patient 1 (b) Patient 2
Figure 2: Plotted are ROM predictions over time (in hours). LBM attributions are visualized in the
background as an image, with red pixels indicating Mft = 1 and white pixels indicating M
f
t = 0.
Red highlighted rectangles are time windows used to compute the average LBM attributions for each
patient.
Figure 3 shows that the model used different feature sets for each patient’s prediction: the model’s
prediction for Patient 1 used a total of 80/270 (30%) features; while it’s prediction for Patient 2
used 48/270 (18%) features. Clinically the individual sets were consistent with the patients’ primary
diagnosis, despite the model knowing no diagnostic information. For example, Patient 1’s top features
included Extremity Temperature Level (rank 1), Lactate (rank 10), and features such as Culture
Urine (rank 20) which were not used for Patient 2’s prediction during the time window of interest.
In contrast, Patient 2’s top features included Respiratory Effort Level (rank 2), FiO2 (rank 3), and
features such as EPAP (rank 9) and IPAP (rank 19) which were not used in Patient 1’s predictions
during the time window of interest. Although the RNN was optimized to predict whether the patient
lives or dies given their physiology and treatments, LBM revealed that the RNN also learned to
indirectly model the patho-physiological processes affecting each unique individual: it highlighted
infection-associated variables for the patients with sepsis, and respiratory-associated variables for
patients with respiratory illness.
5.2 Model “Feature Importance”
The RNN’s feature importance was obtained as described in 4.3 (Equation 8) and shown in Figure 4.
Of the top 10 variables, 6 are qualitative variables manually entered based on the clinician’s judgment
(variables with "Level" in the names and Glascow Coma Score constituents). Moreover, a majority of
the top features were clinical observations measured: vitals, labs, age, and gender. This is consistent
with previously reported results [28], which showed little performance degredation when variables
external to the patients (i.e. interventions and drugs) were excluded as inputs.
This measure of feature importance was further used for feature selection. The top most important
25% features (68/270) were selected and used to train another RNN with the same architecture.
Three RNNs were trained with limited features with different weight initializations and mini-batch
sequencing. The performance of the limited feature models was compared to the full feature set
models, as well as routinely used clinical SOI predictors PIM2 and PRISM3-12 in Figure 5.
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(a) Patient 1
(b) Patient 2
Figure 3: Salient features used by the model in making predictions for a) Patient 1 and b) Patient 2
aggregated over each patient’s time windows of interest (see Figure 2). Note that features that do not
contribute to the predictions during the time windows of interest are not shown.
Figure 4: Model “feature importance” computed from LBM attributions, separated by variable types.
Also shown in the top right are the top 15 features (top right) no longer separated by variable types.
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Unlike feature importance extracted from models such as the Random Forest, there is no guarantee
that feature selection based on LBM attributions (and thus simply the frequency of use of that feature
for making predictions) will maintain or improve predictive performance. Interestingly, the RNN
with limited features maintained similar performance with the original model with full 270 features.
This is consistent with previous work which showed that including extraneous variables slightly
reduced performance [32].
Figure 5: ROC Curves of a RNN trained using all 270 features (rnn_baseline), RNN trained using
features selected from LBM’s feature importance (rnn_limited), and two clinical algorithms routinely
used in the unit PIM2 and PRISM3-12. Displayed are the average (bold lines) and standard deviation
(shaded region) over three iterations for both types of RNN.
6 Discussion
LBM builds upon the formalization of “meta-predictors” in Fong and Vedaldi [5]. Although it was
adapted for an RNN mortality model, the LBM’s formulation is independent of model and data, and
thus is applicable to problems outside of time-series data and recurrent neural networks. Because it
generates a binary mask, any combination of data-modalities is possible, with proper visualization
and interpretation. Moreover, because it only operates on the inputs and does not utilize layer-specific
mechanics, it can be applied to any differentiable neural network model.
LBM has limitations and potential for improvement. It is computationally expensive; it must find
an optimal mask for each individual sample of the dataset. Moreover, because LBM solves an
optimization problem, there is no guarantee of a unique solution and different hyper-parameters
may generate different (and even contradictory) masks. On the other hand, LBM’s sensitivity to
hyper-parameters may also be leveraged to improve the algorithm; for example, multiple LBM masks
with varying hyperparameters (and thus regularizations) can be applied to a patient’s prediction. These
masks can be averaged, generating a real-valued mask (as opposed to binary) where features at each
time step are now represented by a "percentage of importance" based on the varying regularization
parameters and thus varying masks. To further understand the sensitivity LBM to hyper-parameters,
as well as its effectiveness in other problems, future work includes applying and evaluating LBM on
additional problems.
In addition to building confidence in the model, LBM can also reveal idiosyncrasies in the model. For
example, “Patient Mood Level” is the 12th ranked feature in Figure 4 in making predictions of whether
a patient will live or die. The model’s use of this feature may be considered "leakage" of information,
depending on the use-case for the model. If the model’s purpose was to only predict ICU mortality,
then the qualitative measurement of the patient’s mood should be included. However, if the model’s
purpose was to approximate the dynamics of severity of illness based on the patho-physiologic
process of the patient’s illness, then the feature should be excluded.
Similar to LBM’s aggregation over the entire dataset to obtain feature importance of the model, LBM
attribution matrices can also be aggregated over patient populations to obtain feature importance
within cohorts of interest – potentially describing risk factors for mortality across different diseases.
However, because diagnoses labels are unreliable [33], a patient may progress through multiple
diseases during their ICU stay and attributions averaged over entire ICU encounters may mask
significant attributions of each disease and thus cannot be used to easily determine risk factors.
With more reliable, time-stamped diagnosis labels, mortality risk factors can easily be obtained; for
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example, risk factors for the ARDS population can be found by averaging the LBM attributions
across each cohort during the annotated time of the diagnosis label.
7 Conclusion
Learned Binary Masks was developed and used to investigate the mechanics of a recurrent model
trained to predict an individual patient’s ROM. LBM showed that the model contained clinically-
consistent dynamics when determining the patients’ ROM. Moreover, LBM attributions can be
aggregated to obtain the model’s “feature importance”. Using this measure of feature importance for
feature selection, a limited-feature model using only 25% of the features also performed well.
The method is both data- and model-agnostic and is readily interpretable. Furthermore, it can be
aggregated in multiple ways to interpret the model at different scales. Future work includes applying
LBM to additional problems, evaluating its effectiveness in explaining a model’s prediction across
different domains, and improving the algorithm.
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Appendix A Training, Architecture, and Implementation of RNN
The data were partitioned into 50/25/25 percent splits into train/valid/test sets respectively. The
training set (5885 encounters, 4.0% mortality) was used for directly optimizing the RNN weights;
the validation set (1962 encounters, 3.9% mortality) was used to select the best performing weights
and network hyper-parameters, and the test set (2008 encounters, 4.1% mortality) was used reporting
performance. The data were split by patients, instead of encounters, to prevent leakage that can
result from training and testing on the same patient. The label used for training were the outcomes:
whether the patient lived or died at the end of their ICU encounter. Because the desired output is
many-to-many, the RNN was optimized to predict this label for each time-step.
The particular RNN variant used was the Long Short Term Memory (LSTM) [34]. The network
architecture consisted of 3 stacked LSTMs with hidden units 128, 256, 128 and a final fully-connected
layer with an output sigmoid activation. Each layer weights were initialized using Glorot uniform
[35]. The RNN weights were optimized using RMSprop [29] to minimize the binary cross-entropy
loss with an initial learning rate of 10−5 and minibatch size of 128. The learning rate was decreased
by a factor of 10 if there was no improvement in training loss over 10 epochs. If the learning rate was
decimated 3 times or training exceeded 2000 minibatches, the training was terminated.
Appendix B Feature List
Table 1: List of 270 features used for training the RNN model.
Abdominal Girth Cefazolin_inter Glascow Coma Score Methadone_inter PT
ABG Base excess Cefepime_inter Glucose Methylprednisolone_inter PTT
ABG FiO2 Cefotaxime_inter Glycopyrrolate_inter Metoclopramide_inter Pulse Oximetry
ABG HCO3 Ceftazidime_inter Head Circumference Metronidazole_inter Racemic Epi_inter
ABG O2 sat Ceftriaxone_inter Heart Rate Micafungin_inter Ranitidine_inter
ABG PCO2 Central Venous Line Site Height Midazolam HCl_cont RBC Blood
ABG pH Central Venous Pressure Hematocrit Midazolam HCl_inter RDW
ABG PO2 Cerebral Perfusion Pressure Hemofiltration Fluid Output Milrinone_cont Respiratory Effort Level
ABG TCO2 Chest X Ray Hemoglobin Monocytes % Respiratory Rate
Acetaminophen_inter Chloride Heparin_cont Morphine_cont Rifampin_inter
Acetaminophen/Codeine_inter Chlorothiazide_inter Heparin_inter Morphine_inter Right Pupil Size After Light
Acetazolamide_inter Ciprofloxacin HCL_inter Hydrocortisone_inter Motor Response Level Right Pupil Size Before Light
Activity Level Cisatracurium_cont Hydromorphone_cont MRI Brain Right Pupillary Response Level
Acyclovir_inter Clindamycin_inter Hydromorphone_inter MVBG HCO3 Risperidone_inter
Age Clonidine HCl_inter Ibuprofen_inter MVBG O2 Sat Rocuronium_inter
Albumin Level Creatinine Immune Globulin_inter MVBG PCO2 Schistocytes
Albumin_inter CT Brain Influenza Lab MVBG pH Sex_F
Albuterol_inter Culture Blood INR MVBG PO2 Sildenafil_inter
Alkaline phosphatase Culture CSF Inspiratory Time MVBG TCO2 Skin Turgor_turgor
Allopurinol_inter Culture Respiratory Insulin_cont Myelocytes % Sodium
ALT Culture Urine Insulin_inter Naloxone HCL_inter Sodium Bicarbonate_inter
Alteplase_inter Cyclophosphamide_inter Intracranial Pressure Nasal Flaring Level Sodium Chloride_inter
Amikacin_inter Desmopressin_inter IPAP Neutrophils % Sodium Phosphate_inter
Amphotericin B Lipid Complex_inter Dexamethasone_inter Ipratropium Bromide_inter Nifedipine_inter Spironolactone_inter
Ampicillin_inter Dexmedetomidine_cont Isradipine_inter NIV Mode Sucralfate_inter
Ampicillin/Sulbactam_inter Diastolic Blood Pressure Ketamine_inter NIV Set Rate Systolic Blood Pressure
Arterial Line Site Diphenhydramine HCl_inter Ketorolac_inter Norepinephrine_cont Temperature
AST Dopamine_cont Labetalol_inter Nystatin_inter Tidal Volume Delivered
Atropine_inter Dornase Alfa_inter Lactate O2 Flow Rate Tidal Volume Expiratory
Azithromycin_inter Eosinophils % Lactobacillus_inter Octreotide Acetate_cont Tidal Volume Inspiratory
Baclofen_inter EPAP Lansoprazole_inter Olanzapine_inter Tobramycin_inter
Bands % Epinephrine_cont Left Pupil Size After Light Ondansetron_inter Topiramate_inter
Basophils % Epinephrine_inter Left Pupil Size Before Light Oseltamivir_inter Triglycerides
Bicarbonate Serum Epoetin_inter Left Pupillary Response Level Oxacillin_inter Trimethoprim/Sulfamethoxazole_inter
Bilirubin Total EtCO2 Levalbuterol_inter Oxycodone_inter Ursodiol_inter
Budesonide_inter Extremity Temperature Level Level of Consciousness Oxygen Mode Level Valproic Acid_inter
Bumetanide_inter Eye Response Level Levetiracetam_inter Oxygenation Index Vancomycin_inter
BUN Factor VII_inter Levocarnitine_inter Pantoprazole_inter Vasopressin_cont
C-Reactive Protein Famotidine_inter Levothyroxine Sodium_inter PaO2 to FiO2 VBG Base excess
Calcium Chloride_cont Fentanyl_cont Lidocaine_inter Patient Mood Level VBG FiO2
Calcium Chloride_inter Fentanyl_inter Linezolid_inter Peak Inspiratory Pressure VBG HCO3
Calcium Gluconate_inter Fibrinogen Lipase PEEP VBG O2 sat
Calcium Ionized Filgrastim_inter Lorazepam_inter Pentobarbital_inter VBG PCO2
Calcium Total FiO2 Lymphocyte % Phenobarbital_inter VBG pH
Capillary Refill Delayed FLACC Pain Intensity Magnesium Level Phosphorus level VBG PO2
Capillary Refill Rate Fluconazole_inter Magnesium Sulfate_inter Piperacillin/Tazobactam_inter VBG TCO2
CBG Base excess Foley Catheter Volume MCH Platelet Count Vecuronium_inter
CBG FiO2 Fosphenytoin_inter MCHC Potassium Ventilator Rate
CBG HCO3 Furosemide_cont MCV Potassium Chloride_inter Verbal Response Level
CBG O2 sat Furosemide_inter Mean Airway Pressure Potassium Phosphate_inter Vitamin K_inter
CBG PCO2 Gabapentin_inter Mean Arterial Pressure Pressure Support Volume Tidal
CBG pH Ganciclovir Sodium_inter Mechanical Ventilation Mode Propofol_inter Voriconazole_inter
CBG PO2 Gastrostomy Tube Location Meropenem_inter Propranolol HCl_inter Weight
CBG TCO2 Gastrostomy Tube Volume Metamyelocytes % Protein Total White Blood Cell Count
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